 Company management will host a conference call and webcast with slides to discuss its financial results and provide a general business update at 4:30 p.m. ET on the same day. Capricor Therapeutics, Inc. CAPR is a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class biological therapeutics for the treatment and prevention of diseases. 